(Hypertension. 1999;33:598-606.)
© 1999 American Heart Association, Inc.
Awards |
Merck New Investigator Award 1998
The purpose of the Merck New Investigator Award is to encourage young investigators to undertake or continue hypertension research and participate in the conference. The award permits a young investigator to travel to the annual meeting and to present research orally or in poster format and to engage in discussion with senior investigators. The candidates are young investigators (MD or PhD), fellows in training, and academicians who hold an academic rank no higher than that of instructor at the time of submission of an abstract. Each awardee (up to 10) receives $1,000.
The Merck New Investigator Award/Latin America is presented
with the same criteria to up to five qualified new investigators who
plan to pursue their careers in Latin America. Each awardee receives
$2,000.
{texp}Dr Masashi Yanagisawa received the Novartis Award in Hypertension
Research for his discovery of endothelin and his studies of its role in
hypertension and vascular biology. He received his MD and PhD from the
University of Tsukuba in Japan and joined the faculty of Kyoto
University in 1991 as an Assistant Professor of Medicine. He later
moved to the University of Texas Southwestern Medical School in Dallas
as an Associate Professor of Molecular Genetics. He is currently a
Professor of Molecular Genetics and a Howard Hughes Investigator at the
institution and holds the George L. MacGregor Distinguished Chair in
Biomedical Science. He has published over 130 articles in major
scientific journals. His discovery of the endothelins marked a
milestone in cardiovascular research and has stimulated academic